TrialResults-center.org

Menu

Policosanol cholesterol lowering intervention

Cardiovascular prevention

All chronical situations: 3 trials - Más - Batista - Castano

policosanol vs control

No demonstrated result

Endpoint	TE [95% CI]	p val	I2	n	k	trials
Venous thromboembolism	no data
cardiovascular events	no data
Cardiovascular death	no data
stroke (fatal and non fatal)	no data
Coronary event	no data
Coronary death and non fatal MI	no data
Coronary death	no data
cardiac death	0.54 [0.04 6.61]	p=1.00	0	493	2	Más,Castano,
MACE	no data
Non fatal MI	no data
All cause death	0.23 [0.04 1.43]	p=1.00	0	522	3	Más,Batista,Castano,
non cardiovascular death	no data
Fatal stroke	no data
Haemmorhagic stroke	no data
new-onset diabetes	no data
Death from cancer	no data
Rhabdomyolysis	no data
Myopathy	no data
Cancer	no data
Adverse events	no data

TE: treatment effect; CI: confidence interval; k: nulmber of trials; n: total number of patients

See more clinical conditions

Patients with other atherosclerotic localisation: 1 trials - Castano

policosanol vs control

No demonstrated result

Endpoint	TE [95% CI]	p val	I2	n	k	trials
Venous thromboembolism	no data
cardiovascular events	no data
Cardiovascular death	no data
stroke (fatal and non fatal)	no data
Coronary event	no data
Coronary death and non fatal MI	no data
Coronary death	no data
cardiac death	0.36 [0.01 9.19]	p=1.00	0	56	1	Castano,
MACE	no data
Non fatal MI	no data
All cause death	0.21 [0.01 4.69]	p=1.00	0	56	1	Castano,
non cardiovascular death	no data
Fatal stroke	no data
Haemmorhagic stroke	no data
new-onset diabetes	no data
Death from cancer	no data
Rhabdomyolysis	no data
Myopathy	no data
Cancer	no data
Adverse events	no data

TE: treatment effect; CI: confidence interval; k: nulmber of trials; n: total number of patients

Modal title

- About - Browse pathology | treatment - Site map - Credits Made with in Lyon - Contact us - Privacy policy -